title: Clinical outcome of patients with uterine sarcomas.
abstract: OBJECTIVE
  The aim of our retrospective analysis was to study and report the clinical outcome of patients with uterine sarcoma (US) treated at our center; and to share our experience with literature.
  
  
  METHODS
  We retrieved the information regarding the patient's demography, clinico-pathological details, treatment given, survival, and complications of all the US patients treated at our center between the years 2000-2008. The three-year overall survival (OS) was determined with respect to various prognostic factors like age, stage of disease, histopathological type, adjuvant RT etc.
  
  
  RESULTS
  A total of 50 case records were retrieved for this retrospective analysis. Age ranged from 24 to 75 years with a median of 50 years. Carcinosarcoma was the commonest histopathological type (23/50 patients). FIGO stage distribution was: stage I, 27; stage II, 7; stage III, 12; stage IV, 2; and unknown stage, two patients. Forty-eight patients underwent surgery; 31 received postoperative radiation therapy (PORT) and 16 received chemotherapy therapy. Median follow-up period was 34 months (range 2-69 months). The three-year OS for the entire group of patients was 42%. Stage of the disease, histopathological type, and use of PORT were found significant prognostic factors for survival.
  
  
  CONCLUSIONS
  Although limited by small sample size and retrospective nature, ours is the only study on US being reported from India. Our results have demonstrated FIGO stage of the disease, histopathology and use of PORT to be the significant prognostic factor for survival. Use of chemotherapy in future trials is warranted.
authors: Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India. sharmadn@hotmail.com
authors: Daya Nand
authors: DN
authors: Sharma
authors: Goura Kisor
authors: GK
authors: Rath
authors: Sunesh
authors: S
authors: Kumar
authors: Lalit
authors: L
authors: Kumar
authors: Neerja
authors: N
authors: Bhatla
authors: Ajeet Kumar
authors: AK
authors: Gandhi
authors: Roopa
authors: R
authors: Hariprasad
mesh_terms: D000328:Adult; D000368:Aged; D002296:Carcinosarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012509:Sarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D018203:Sarcoma, Endometrial Stromal / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D055815:Young Adult